Formycon AG
Formycon AG, a biotechnology company, develops biosimilar drugs in Germany and Switzerland. It provides FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of ...
Formycon AG Logo
About Formycon AG
Formycon AG is a biopharmaceutical company with more than twelve years experience in product development. The company's activities focus on developing and marketing "biosimilars" - biopharmaceuticals which are similar to existing drugs for which patent protection is expiring - as well as the provision of contract services to other biotechnology and pharmaceutical companies.
Address
Fraunhoferstrasse 15, Martinsried
Planegg, 82152
Germany
Year founded
2012
Number of employees
238
